玻璃体内注射曲安奈德植入物治疗匐行性脉络膜炎。
Treatment of serpiginous choroiditis with intravitreous fluocinolone acetonide implant.
作者信息
Seth Rajeev K, Gaudio Paul A
机构信息
Department of Ophthalmology and Visual Science, Yale University School of Medicine, New Haven, Connecticut 06510, USA.
出版信息
Ocul Immunol Inflamm. 2008 May-Jun;16(3):103-5. doi: 10.1080/09273940802023778.
PURPOSE
To describe a case in which a fluocinolone acetonide implant was used in a patient with serpiginous choroiditis.
DESIGN
Case report.
RESULTS
A 57-year-old woman with active serpiginous choroiditis threatening the fovea of her right eye received one intravitreous triamcinolone acetonide injection, leading to immediate disease control. An intravitreous fluocinolone acetonide implant was placed, and resulted in ongoing control of the disease as of her 14 months postoperative follow-up.
CONCLUSIONS
Intravitreous fluocinolone acetonide implant should be recognized as a potential treatment option for serpiginous choroiditis.
目的
描述一例使用醋酸氟轻松植入剂治疗匐行性脉络膜炎患者的病例。
设计
病例报告。
结果
一名57岁患有活动性匐行性脉络膜炎且累及右眼黄斑中心凹的女性患者接受了一次玻璃体内曲安奈德注射，疾病得到了即刻控制。随后植入了玻璃体内醋酸氟轻松植入剂，术后14个月随访时疾病仍处于可控状态。
结论
玻璃体内醋酸氟轻松植入剂应被视为匐行性脉络膜炎的一种潜在治疗选择。
Zotero 插件